Related Experiment Video
Updated: Mar 31, 2026
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Unique Challenges of Type 1 Diabetes in the Preschool Population
Loyal K Coshway1, Robert P Hoffman
1Name Loyal K. Coshway, 700 Children's Dr, Columbus, Oh 43205, United States.
Insights
Type 1 diabetes in very young children presents unique challenges, including glycemic control and neurocognitive risks. Insulin pumps and continuous glucose monitoring offer benefits, but require careful management for optimal outcomes in this age group.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Child Health
Background:
- Children aged ≤6 years with type 1 diabetes (T1D) exhibit distinct glycemic variability, management needs, and complication risks.
- This age group faces challenges like frequent hypo- and hyperglycemia, hypoglycemia unawareness, and reduced beta-cell function.
Purpose of the Study:
- To delineate the specific characteristics of diabetes care and outcomes in preschool-aged children with T1D.
- To highlight the unique management strategies and potential long-term effects in this population.
Main Methods:
- A comprehensive literature search was conducted using PubMed, Google Scholar, and author bibliographies.
- Articles specifically focusing on type 1 diabetes in preschool-aged children were extracted and analyzed.
Main Results:
- Preschoolers with T1D experience more frequent glycemic fluctuations and are at higher risk for neurocognitive effects from severe hypoglycemia and hyperglycemia.
- While multiple daily injections and insulin pumps yield similar metabolic control, insulin pumps and sensor-augmented pump therapy show potential for improved outcomes (lower HbA1c, reduced hypoglycemia).
- Continuous glucose monitoring aids parental oversight for hypoglycemia but has limited impact on HbA1c in this group; early T1D onset increases risk for microalbuminuria but not earlier retinopathy.
Conclusions:
- Specialized knowledge of T1D management in very young children is crucial for healthcare providers and caregivers.
- Understanding the unique challenges and benefits of different technologies is essential for optimizing care and long-term health in this population.
Background:
Extremely young children aged ≤6 years old represent a unique population among patients with type 1 diabetes in terms of glycemic variation, diabetes management and complications.
Objective:
We describe distinct features of diabetes care and outcomes in preschool age children.
Methods:
We searched PubMed, Google Scholar, and authors' bibliographies in order to extract articles specific to type 1 diabetes in preschool age children.
Findings:
The preschool age group is beset by many challenges to diabetes care, including more frequent hypo- and hyperglycemia, hypoglycemia unawareness, decreased residual beta cell function, and greater long-term neurocognitive effects from severe hypoglycemia and chronic hyperglycemia. Randomized controlled trials show that equally good metabolic control can be obtained with multiple daily injections or an insulin pump. Several non-randomized trials, including an 8 year longitudinal study, show lower hemoglobin A1C and decreased hypoglycemia on insulin pumps. Sensor augmented pump therapy resulted in superior A1C as long as sensors were used regularly. In contrast to adults, continuous glucose monitoring has little to no impact on A1C, although parents appreciate the improved monitoring for hypoglycemia. Children with onset of diabetes prior to age 5 are at risk for younger onset of microalbuminuria, however do not develop earlier onset retinopathy than children diagnosed after 5 years. Both severe hypoglycemia and chronic hyperglycemia have negative impact on neurocognition.
Conclusion:
Special knowledge about this young population is helpful for practitioners and parents.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:16Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...